title: Evidence of absorptive hypercalciuria in tuberculosis patients.
abstract: In patients with granulomatous diseases, disturbances in calcium metabolism have been described. The aim of the study was to evaluate alterations in calcium metabolism in patients with tuberculosis. Forty patients with tuberculosis (TB) were studied in a baseline state (calcium intake 1000 mg/day). Fourteen of these patients were also studied after restrictive calcium diet (400 mg/calcium/day) and after a load of oral calcium of 1000 mg. In all the studies, calcium and phosphorus were measured in serum and urine, and parathyroid hormone (PTH) in plasma. In addition, serum 25OHD and 1,25(OH)2D (calcitriol) levels were measured in the baseline state and after the restrictive diet. In the baseline state, 25OHD levels were lower and urinary calcium higher in TB patients than in the control group. No patients had hypercalcemia, but hypercalciuria was present in 10 patients (25%). The patients with tuberculosis were divided according to the presence or absence of hypercalciuria. In both groups, the 25OHD levels were lower than in controls. Hypercalciuric patients had lower plasma parathyroid hormone levels and higher serum calcitriol levels than the control group and the TB patients without hypercalciuria. Urinary calcium excretion after a calcium load was higher in TB patients with hypercalciuria than in controls. A positive correlation was found between the calcitriol levels and postcalcium load urinary calcium excretion in patients with calcium hyperabsorption. These data indicate that absorptive hypercalciuria is frequently observed in patients with TB and is possible due to inappropriately high serum calcitriol levels.
authors.affiliation: Biochemistry Department, Hospital La Paz, Universidad Autonoma de Madrid, Spain.
authors.forename: M E
authors.initials: ME
authors.lastname: Martinez
authors.forename: J
authors.initials: J
authors.lastname: Gonzalez
authors.forename: M J
authors.initials: MJ
authors.lastname: Sanchez-Cabezudo
authors.forename: J M
authors.initials: JM
authors.lastname: Peña
authors.forename: J J
authors.initials: JJ
authors.lastname: Vazquez
authors.forename: A
authors.initials: A
authors.lastname: Felsenfeld
mesh_terms: D000042:Absorption; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood / Q000652:urine*; D002136:Calcium, Dietary / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood; D007684:Kidney Tubules / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood / Q000652:urine*; D010758:Phosphorus / Q000097:blood / Q000652:urine; D014376:Tuberculosis / Q000652:urine*
chemical_list: D002136:Calcium, Dietary; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010758:Phosphorus; D002117:Calcitriol; D002118:Calcium